BRIDGEWAY CAPITAL MANAGEMENT, LLC - ARROWHEAD PHARMACEUTICALS IN ownership

ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 83 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q1 2017. The put-call ratio across all filers is 1.68 and the average weighting 0.0%.

Quarter-by-quarter ownership
BRIDGEWAY CAPITAL MANAGEMENT, LLC ownership history of ARROWHEAD PHARMACEUTICALS IN
ValueSharesWeighting
Q1 2018$1,442,000
+78.7%
200,000
-8.8%
0.02%
+66.7%
Q4 2017$807,000
-6.8%
219,200
+9.6%
0.01%
-10.0%
Q3 2017$866,000
+167.3%
200,0000.0%0.01%
+150.0%
Q2 2017$324,000
-12.4%
200,0000.0%0.00%0.0%
Q1 2017$370,000200,0000.00%
Other shareholders
ARROWHEAD PHARMACEUTICALS IN shareholders Q1 2017
NameSharesValueWeighting ↓
ELEMENT CAPITAL MANAGEMENT LLC 142,649$618,0000.25%
ING GROEP NV 808,229$3,500,0000.07%
A.R.T. Advisors, LLC 232,470$1,006,0000.05%
OppenheimerFunds, Inc. 3,000,000$12,990,0000.02%
Edge Wealth Management LLC 10,000$43,0000.01%
First Allied Advisory Services, Inc. 61,000$264,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 200,000$866,0000.01%
MILLENNIUM MANAGEMENT LLC 1,272,138$5,508,0000.01%
D. E. Shaw & Co., Inc. 971,768$4,208,0000.01%
Virtu Financial LLC 18,008$78,0000.00%
View complete list of ARROWHEAD PHARMACEUTICALS IN shareholders